As per MRFR analysis, the GCC Ophthalmic Viscoelastic Devices Market Size was estimated at 120.12 (USD Million) in 2023. The GCC Ophthalmic Viscoelastic Devices Market Industry is expected to grow from 128.94(USD Million) in 2024 to 540 (USD Million) by 2035. The GCC Ophthalmic Viscoelastic Devices Market CAGR (growth rate) is expected to be around 13.906% during the forecast period (2025 - 2035).
Key GCC Ophthalmic Viscoelastic Devices Market Trends Highlighted
The GCC Ophthalmic Viscoelastic Devices Market is currently influenced by several key market drivers, primarily the rising prevalence of eye disorders and an increasing geriatric population within the region. Governments in GCC countries are investing significantly in healthcare infrastructure and promoting medical tourism, thereby enhancing access to advanced ophthalmic procedures. This investment is complemented by a growing awareness among the population regarding eye health, which is driving demand for surgeries that utilize viscoelastic devices.
Moreover, the introduction of innovative products by manufacturers is playing a critical role in fuelling market growth, as these devices are increasingly being designed to offer enhanced safety and efficacy in various ophthalmic surgeries.New possibilities in the market are opening up as the hospitals in the area start to expand their services.
The market growth for advanced viscoelastic devices is becoming easier for manufacturers to navigate due to the ever-increasing need for advanced, minimally invasive surgeries. Moreover, there is an increase in the partnerships established between local distributors and foreign manufacturers, which improves access to new technologies and aids in knowledge transfer.
Recent developments indicate that multi-functional viscoelastic devices that assist in the recovery of patients post-surgery are also gaining traction.Furthermore, the regulatory framework in the GCC is evolving, making it more conducive for new product entries while ensuring high safety and efficacy standards. This regulatory support, combined with the focus on patient-centered care, continues to shape the dynamics of the GCC Ophthalmic Viscoelastic Devices Market, making it a vibrant arena for future development.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
GCC Ophthalmic Viscoelastic Devices Market Drivers
Increasing Incidence of Eye Disorders
The rise in the incidence of eye disorders such as cataracts and glaucoma is a significant driver for the GCC Ophthalmic Viscoelastic Devices Market Industry. According to the World Health Organization, the prevalence of cataracts is expected to increase due to the aging population, suggesting that 29.5 million individuals in the GCC will be 60 years or older by 2050.
This demographic shift leads to heightened demand for ophthalmic surgeries, thereby propelling the need for ophthalmic viscoelastic devices.Prominent organizations like the Saudi Ophthalmology Society are actively involved in raising awareness and promoting eye health initiatives, contributing to the market demand in this region.
Technological Advancements in Surgical Techniques
The advancements in minimally invasive surgical techniques have increased the adoption of ophthalmic viscoelastic devices in the GCC Ophthalmic Viscoelastic Devices Market Industry. Innovative technologies such as phacoemulsification have revolutionized cataract surgeries, significantly improving patient outcomes and reducing recovery times.
Research from the United Arab Emirates Ministry of Health and Prevention indicates a 15% increase in surgeries utilizing modern techniques, which consequently boosts the demand for high-quality viscoelastic devices that facilitate these procedures.Established companies like Alcon and Bausch + Lomb are leading this innovation, further solidifying the market growth in the region.
Growing Healthcare Expenditure
Increasing healthcare expenditure in GCC countries is a critical factor driving the GCC Ophthalmic Viscoelastic Devices Market Industry. The GCC governments are prioritizing healthcare development, as evidenced by the Saudi Vision 2030 program, which aims to improve the overall healthcare system and double the expenditure on health services.
Reports indicate an annual growth of 7% in healthcare spending in the region, which translates to greater access to advanced ophthalmic treatments and devices.This trend emphasizes the increasing capacity of health institutions in the region to invest in the latest technologies and viscoelastic products, thus presenting a favorable market outlook.
GCC Ophthalmic Viscoelastic Devices Market Segment Insights
Ophthalmic Viscoelastic Devices Market Type Insights
The GCC Ophthalmic Viscoelastic Devices Market is characterized by its division into several types, notably Cohesive Ocular Viscoelastic Devices (OVDs) and Dispersive OVDs, which play crucial roles in ophthalmic surgical procedures.
Cohesive OVDs are primarily used for maintaining ocular space during surgery due to their ability to provide better stability and visibility, significantly reducing issues such as corneal endothelial damage. This type is known for its efficient retention of intraocular pressure, making it pivotal in procedures like cataract surgery, where surgical precision is key.
On the other hand, Dispersive OVDs are essential for ensuring optimal tissue protection and minimizing trauma to ocular tissues during intraocular interventions. Their unique viscous properties facilitate smooth interactions between instruments and delicate eye structures, promoting effective surgical outcomes.
Both types of OVDs are witnessing increased adoption in the GCC region, driven by rising surgical procedures and advancements in ophthalmic technologies. The increasing prevalence of eye-related disorders in GCC countries necessitates the use of sophisticated surgical aids like these viscoelastic devices.Furthermore, the demand for minimally invasive surgeries, paired with the rising number of healthcare facilities in the GCC dedicated to eye care, is anticipated to catalyze growth in this segment.
The region’s focus on enhancing healthcare infrastructure and investing in Research and Development for innovative ophthalmic solutions further solidifies the importance of both Cohesive and Dispersive OVDs in meeting the evolving needs of ophthalmic surgery. As such, the segmentation of the GCC Ophthalmic Viscoelastic Devices Market into these key types reflects the industry's responsiveness to the dynamic needs of medical professionals and patients alike, signifying their critical role in improving surgical outcomes and patient care within the region.
Moreover, the diverse applications and advantages each type offers contribute to their overall significance in the ophthalmology field, ensuring that practitioners can select the best options tailored to specific surgical scenarios. The ongoing trends toward improved patient outcomes and operational efficiencies in surgeries highlight the essential nature of Cohesive and Dispersive OVDs in the landscape of ophthalmic devices, further showcasing their relevance in the GCC healthcare market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Ophthalmic Viscoelastic Devices Market Application Insights
The Application segment of the GCC Ophthalmic Viscoelastic Devices Market encompasses critical procedures such as Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, and Vitreoretinal Surgery, each serving a significant role in eye health management. Cataract Surgery continues to dominate the landscape due to the high prevalence of cataracts in the aging population across the GCC region.
Glaucoma Surgery is also vital, addressing a leading cause of irreversible blindness, making advancements in this area essential for improving patient outcomes.Meanwhile, Corneal Transplantation applications support those suffering from corneal diseases, enabling restored vision and quality of life. Lastly, Vitreoretinal Surgery plays a crucial role in treating complex retinal conditions, benefiting from innovative viscoelastic technology that enhances surgical precision.
Collectively, these applications illustrate the growing demand for sophisticated ophthalmic solutions, driven by an increase in eye disorders and the expansion of healthcare infrastructure in the GCC. As healthcare providers continue to invest in advanced ophthalmic technologies, the market is expected to grow in response to these evolving patient needs and technological advancements.
Ophthalmic Viscoelastic Devices Market End User Insights
The End User segment of the GCC Ophthalmic Viscoelastic Devices Market encompasses a diverse range of entities, including Ophthalmic Clinics and Phaco Centers, Hospitals, and Academic and Research Institutes. Ophthalmic Clinics and Phaco Centers are crucial as they provide specialized services focused on cataract surgeries and other ocular procedures, often utilizing advanced viscoelastic devices for optimal surgical outcomes.
Hospitals play a significant role in the overall healthcare landscape, as they host a variety of ophthalmic procedures and are equipped with the necessary technology to accommodate high patient volumes.Additionally, Academic and Research Institutes contribute significantly by advancing knowledge, conducting clinical trials, and fostering innovation in viscoelastic devices, which enhances overall treatment efficacy and patient care standards.
The demand for these devices in the GCC region is driven by an increasing prevalence of ocular diseases, a growing aging population, and heightened awareness about eye health, paving the way for sustained market growth. Overall, each of these end users contributes uniquely to the ongoing development and application of ophthalmic viscoelastic devices within the GCC region, reflecting a nuanced and expanding market landscape.
GCC Ophthalmic Viscoelastic Devices Market Key Players and Competitive Insights
The GCC Ophthalmic Viscoelastic Devices Market is experiencing a dynamic competitive landscape characterized by a growing demand for advanced surgical products that enhance patient outcomes in ophthalmic procedures. Key players in this market are consistently innovating to develop products with improved performance, safety, and efficacy while adhering to stringent regulatory standards. The rise in cataract surgeries and an increase in awareness about vision-related issues are driving the market forward. Additionally, advancements in technology and the introduction of novel viscoelastic formulations are expected to further augment the market's growth trajectory.
Companies are strategizing around their product lines, market penetration strategies, and collaborative partnerships to maintain a competitive edge in this evolving environment.Surgeon Pharmaceuticals has established a solid foothold in the GCC Ophthalmic Viscoelastic Devices Market through its comprehensive product offerings that cater to the needs of ophthalmic surgeons.
Known for its innovative approach, Surgeon Pharmaceuticals focuses on the development of high-quality viscoelastic solutions that enhance surgical performance and patient safety during procedures such as cataract surgery and glaucoma treatments. The company's strengths lie in its commitment to research and development, which allows it to stay ahead of industry trends and meet the specific requirements of the regional market.
Their strong distribution network and strategic partnerships with healthcare professionals reinforce their market presence, ensuring accessibility and support for their products within the GCC.Abbott Laboratories is also a significant player in the GCC Ophthalmic Viscoelastic Devices Market, known for its commitment to advancing eye care through innovative products and solutions.
The company boasts a diverse portfolio that includes a range of viscoelastic devices used in various surgical applications. With a strong focus on research and development, Abbott Laboratories is continuously enhancing its key products, which are recognized for their high performance and reliability.
The company’s strengths in the GCC region stem from its extensive market presence supported by rigorous clinical studies that validate the effectiveness of its products. Abbott has been active in pursuing strategic partnerships and collaborations while also exploring mergers and acquisitions to bolster its standing in the market, making it a formidable competitor in the ophthalmic sector within the GCC.
Key Companies in the GCC Ophthalmic Viscoelastic Devices Market Include
GCC Ophthalmic Viscoelastic Devices Market Industry Developments
The GCC Ophthalmic Viscoelastic Devices Market has seen dynamic developments recently, particularly in the context of growth and innovation. In September 2023, Santen Pharmaceutical announced an expansion of its product offerings within the region, highlighting its commitment to addressing local healthcare needs.
Meanwhile, Abbott Laboratories reported a surge in demand for its ophthalmic products, contributing positively to its market share in the GCC. In recent years, particularly in July 2022, Staar Surgical launched new advancements in its viscoelastic solutions, enhancing its presence in the market. Additionally, mergers and acquisitions have played a crucial role, with Johnson and Johnson acquiring a niche player in the industry in April 2023, strengthening its portfolio and presence in ophthalmic applications.
Growth in market valuation, driven by factors such as an increase in ocular surgeries and rising awareness of eye health in the GCC, has further propelled interest in the field, especially from companies like Bausch Health Companies and Novartis AG. Overall, the balance of innovation, demand, and strategic acquisitions has significantly shaped the landscape of the GCC Ophthalmic Viscoelastic Devices Market in recent years.
GCC Ophthalmic Viscoelastic Devices Market Segmentation Insights
Ophthalmic Viscoelastic Devices Market Type Outlook
Ophthalmic Viscoelastic Devices Market Application Outlook
Ophthalmic Viscoelastic Devices Market End User Outlook
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 120.12(USD Million) |
| MARKET SIZE 2024 | 128.94(USD Million) |
| MARKET SIZE 2035 | 540.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.906% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Surgeon Pharmaceuticals, Abbott Laboratories, Edon Pharmaceutical, Santen Pharmaceutical, Vital Tears, Niclai Biosystems, Novartis AG, Carl Zeiss AG, OptiMed Medical, Staar Surgical, Bausch Health Companies, Hyaluronic Acid Technologies, Tissue Regenix, Johnson & Johnson, VivaSight |
| SEGMENTS COVERED | Type, Application, End User |
| KEY MARKET OPPORTUNITIES | Increasing cataract surgeries demand, Rising geriatric population, Advancements in surgical techniques, Growth of ophthalmology clinics, Enhanced product innovations |
| KEY MARKET DYNAMICS | rising cataract surgeries, technological advancements, increasing healthcare expenditure, growing elderly population, regulatory changes in healthcare |
| COUNTRIES COVERED | GCC |
Frequently Asked Questions (FAQ) :
The market size of the GCC Ophthalmic Viscoelastic Devices Market is expected to be valued at 128.94 million USD in 2024.
By 2035, the GCC Ophthalmic Viscoelastic Devices Market is forecasted to reach a valuation of 540.0 million USD.
The expected CAGR for the GCC Ophthalmic Viscoelastic Devices Market from 2025 to 2035 is 13.906%.
In 2024, cohesive OVDs are expected to have a larger market size, valued at 70.0 million USD.
The projected market size for dispersive OVDs in 2035 is 250.0 million USD.
Major players in the market include companies like Abbott Laboratories and Novartis AG, which significantly contribute to market share.
Emerging trends in the market involve advancements in technology and increased demand for minimally invasive surgeries.
The competitive landscape features key players such as Bausch Health Companies and Santen Pharmaceutical, driving innovation and market share.
The growth outlook for the market over the next decade is positive, fueled by a consistent increase in surgical procedures.
Challenges in the market include regulatory hurdles and pricing pressures that may affect profitability.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
